March 25, 2025
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July 2024Signed…
Pharmaceuticals, Biotechnology and Life Sciences
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July 2024Signed…
Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology…
SHELTON, Conn., March 24, 2025 (GLOBE NEWSWIRE) — Abinopharm, Inc., an innovative nutritional and biopharmaceutical company, is pleased to announce…
TALLMADGE, Ohio, March 24, 2025 (GLOBE NEWSWIRE) — Lately, more people are grappling with dental health problems. Whether it’s cavities,…
TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet…
Please read the announcement in PDF Attachment 2025_13_Share_buyback_program
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) — Singlera Genomics presented results showing a refined approach to detect drug-induced testicular…
Saint-Beauzire Facility Saint-Beauzire Production Line for both liquid and lyophilized forms BUBENDORF, Switzerland, March 24, 2025 (GLOBE NEWSWIRE) — Switzerland-based…
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative…
SOUTH SAN FRANCISCO, Calif., March 23, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing…